OBJECTIVES:  Upon completion of this activity, the participant should be able to:

1. Review the Emperor-Reduced trial
2. Discuss impact of SGLT2 inhibitors in reducing HF hospitalization.
3. Identify appropriate patients for starting therapy with SGLT2

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

FACULTY DISCLOSURE: Dr.Divakaran does not have a financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

PLANNER(S) DISCLOSURES: The planner (Dr. Divakaran) does not have a financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.